DE60335536D1 - Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand - Google Patents

Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand

Info

Publication number
DE60335536D1
DE60335536D1 DE60335536T DE60335536T DE60335536D1 DE 60335536 D1 DE60335536 D1 DE 60335536D1 DE 60335536 T DE60335536 T DE 60335536T DE 60335536 T DE60335536 T DE 60335536T DE 60335536 D1 DE60335536 D1 DE 60335536D1
Authority
DE
Germany
Prior art keywords
polypeptide
seq
amino acids
detecting
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60335536T
Other languages
English (en)
Inventor
Scott R Presnell
Wenfeng Xu
Julia E Novak
Theodore E Whitmore
Francis J Grant
Wayne R Kindsvogel
Kevin M Klucher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Zymogenetics LLC
Original Assignee
Bristol Myers Squibb Co
Zymogenetics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Zymogenetics LLC filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE60335536D1 publication Critical patent/DE60335536D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60335536T 2002-04-19 2003-04-18 Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand Expired - Lifetime DE60335536D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37381302P 2002-04-19 2002-04-19
PCT/US2003/012030 WO2003089603A2 (en) 2002-04-19 2003-04-18 Cytokine receptor

Publications (1)

Publication Number Publication Date
DE60335536D1 true DE60335536D1 (de) 2011-02-10

Family

ID=29251089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60335536T Expired - Lifetime DE60335536D1 (de) 2002-04-19 2003-04-18 Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand

Country Status (13)

Country Link
US (7) US20040029228A1 (de)
EP (2) EP1497415B1 (de)
JP (2) JP4409962B2 (de)
CN (2) CN1659274A (de)
AT (1) ATE493438T1 (de)
AU (2) AU2003225055B2 (de)
BR (1) BR0309401A (de)
CA (1) CA2482368A1 (de)
DE (1) DE60335536D1 (de)
ES (1) ES2356307T3 (de)
IL (1) IL164523A0 (de)
RU (1) RU2004133765A (de)
WO (1) WO2003089603A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356046B1 (de) * 2000-11-28 2009-10-14 ZymoGenetics, L.L.C. Zytokine rezeptor zcytor19
TW200300170A (en) * 2001-11-09 2003-05-16 Wyeth Corp Type 2 cytokine receptor and nucleic acids encoding same
US7820793B2 (en) * 2002-02-08 2010-10-26 University Of Medicine And Dentistry Of New Jersey IFN-λ polypeptides and compositions
JP4409962B2 (ja) * 2002-04-19 2010-02-03 ザイモジェネティクス，インコーポレイティド サイトカイン受容体
WO2004037995A2 (en) * 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
EP1668031B1 (de) 2003-08-07 2008-03-12 ZymoGenetics, Inc. Homogene herstellungen von il-29
US20050244423A1 (en) * 2004-04-02 2005-11-03 Klucher Kevin M Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
CN101829318B (zh) * 2004-07-29 2012-07-04 津莫吉尼蒂克斯有限责任公司 Il-28和il-29治疗癌症和自身免疫性疾病的用途
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
CA2616122A1 (en) * 2005-07-20 2007-01-25 Zymogenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
WO2013103981A1 (en) * 2012-01-06 2013-07-11 Ember Therapeutics, Inc. Compositions and methods of use of fndc5 polypeptides
EP2617732A1 (de) * 2012-01-19 2013-07-24 Vib Vzw Werkzeuge und Verfahren zur Expression von Membranproteinen
GB201514875D0 (en) * 2015-08-20 2015-10-07 Autolus Ltd Receptor
US11352631B2 (en) 2015-12-18 2022-06-07 Sangamo Therapeutics, Inc. Targeted disruption of the T cell receptor

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US846A (en) 1838-07-17 Improvement in revolving fire-arms
US5738A (en) 1848-08-29 Francis kelsey
AU560472B2 (en) 1981-08-25 1987-04-09 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4624846A (en) 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3578435D1 (de) 1984-12-06 1990-08-02 Labofina Sa Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5055291A (en) 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
DE68926888T2 (de) 1988-01-22 1997-01-09 Zymogenetics Inc Verfahren zur Herstellung von sekretierten Rezeptoranalogen
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5529932A (en) 1988-01-28 1996-06-25 Pharmacia, S.P.A. Isolated DNA encoding a plant ribosome inactivating protein from the leaves of saponaria officinalis
US5120525A (en) 1988-03-29 1992-06-09 Immunomedics, Inc. Radiolabeled antibody cytotoxic therapy of cancer
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5576288A (en) 1989-04-27 1996-11-19 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5191067A (en) 1989-04-27 1993-03-02 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5635384A (en) 1990-06-11 1997-06-03 Dowelanco Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
US5478804A (en) 1990-09-19 1995-12-26 The Salk Institute For Biological Studies Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
CA2097291A1 (en) 1990-12-13 1992-06-14 David P. Gearing Leukemia inhibitory factor receptors
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
WO1994006463A1 (en) 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
AU6208494A (en) 1993-03-02 1994-09-26 Universidad De Valladolid Non-toxic ribosome inactivating proteins (rips) with two chains, process for the preparation thereof and applications
CA2171192A1 (en) 1993-09-06 1995-03-16 Fiorenzo Stirpe Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
US5443953A (en) 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
CA2169190A1 (en) 1994-02-14 1995-08-17 Richard D. Holly Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5911995A (en) 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5738846A (en) 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
AU1158297A (en) 1995-11-09 1997-05-29 Zymogenetics Inc. Production of gad65 in methylotrophic yeast
IT1286663B1 (it) 1996-06-27 1998-07-15 Ministero Uni Ricerca Scient E Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna
CA2261020C (en) 1996-07-17 2004-06-08 Zymogenetics, Inc. Preparation of pichia methanolica auxotrophic mutants
AU718510B2 (en) 1996-07-17 2000-04-13 Zymogenetics Inc. Transformation of pichia methanolica
EP0942968B1 (de) 1996-12-03 2008-02-27 Amgen Fremont Inc. Vollkommen humane Antikörper die EGFR binden
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
EP0975762B1 (de) 1997-06-06 2011-10-05 PanGenetics B.V. Ribosomen inaktivierendes protein vom typ-1
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO2000024758A1 (en) 1998-10-26 2000-05-04 Ludwig Institute For Cancer Research ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
AU6069300A (en) 1999-07-02 2001-01-22 Chiron Corporation Novel human genes and gene expression products
DE60135393D1 (de) 2000-06-30 2008-09-25 Zymogenetics Inc Allelische Variante des Interferon-ähnlichen Proteins Zcyto21
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
CA2419979A1 (en) * 2000-09-08 2002-03-14 Schering Corporation Mammalian genes; related reagents and methods
EP1356046B1 (de) * 2000-11-28 2009-10-14 ZymoGenetics, L.L.C. Zytokine rezeptor zcytor19
WO2002086087A2 (en) * 2001-04-20 2002-10-31 Zymogenetics, Inc. Cytokine protein family
EP1439223A1 (de) 2001-10-02 2004-07-21 Mochida Pharmaceutical Co., Ltd. Neuer klasse-ii-cytokinrezeptor
TW200300170A (en) * 2001-11-09 2003-05-16 Wyeth Corp Type 2 cytokine receptor and nucleic acids encoding same
US7033787B2 (en) * 2001-12-21 2006-04-25 Ludwig Institute For Cancer Research Isolated cytokine receptor LICR-2
US7820793B2 (en) 2002-02-08 2010-10-26 University Of Medicine And Dentistry Of New Jersey IFN-λ polypeptides and compositions
JP4409962B2 (ja) * 2002-04-19 2010-02-03 ザイモジェネティクス，インコーポレイティド サイトカイン受容体
WO2004037995A2 (en) * 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
CA2516128A1 (en) * 2003-02-14 2004-09-02 Sagres Discovery, Inc. Therapeutic targets in cancer

Also Published As

Publication number Publication date
JP2006504401A (ja) 2006-02-09
US20070048847A1 (en) 2007-03-01
WO2003089603A2 (en) 2003-10-30
AU2009203007A1 (en) 2009-08-13
CA2482368A1 (en) 2003-10-30
ATE493438T1 (de) 2011-01-15
US20120053321A1 (en) 2012-03-01
BR0309401A (pt) 2007-02-21
US20040029228A1 (en) 2004-02-12
CN101676728A (zh) 2010-03-24
US20110171627A1 (en) 2011-07-14
IL164523A0 (en) 2005-12-18
US20070264685A1 (en) 2007-11-15
ES2356307T3 (es) 2011-04-06
EP1497415A4 (de) 2006-03-22
RU2004133765A (ru) 2005-06-27
WO2003089603A3 (en) 2004-09-16
EP2295455A1 (de) 2011-03-16
AU2003225055B2 (en) 2009-04-23
US20070122879A1 (en) 2007-05-31
EP1497415A2 (de) 2005-01-19
US7723298B2 (en) 2010-05-25
AU2003225055A1 (en) 2003-11-03
US20070134727A1 (en) 2007-06-14
CN1659274A (zh) 2005-08-24
EP1497415B1 (de) 2010-12-29
JP4409962B2 (ja) 2010-02-03
JP2009268469A (ja) 2009-11-19

Similar Documents

Publication Publication Date Title
ATE493438T1 (de) Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand
DE69331550D1 (de) Klonierung und expression von biologisch aktiver alpha-galaktosidase a
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
FI107610B (fi) HCV-fuusioproteiini
ATE179459T1 (de) Verfahren zur typisierung von hcv-isolaten
NO20043419L (no) Nytt cytokin, zcytor17-ligand
DE68925083T2 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
ATE398179T1 (de) Von rna polymerasen abstammende polypeptide und ihre verwendungen
DK0484787T3 (da) HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
DE69029092T2 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
HU9200548D0 (en) Improved activity process of recombined proteins
FI880017A0 (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
ATE71110T1 (de) Verfahren zur reinigung eines proteins.
DE69013471D1 (de) Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
ATE57706T1 (de) Waessrige dispersion eines additionspolymers, ueberzugsmasse daraus und verfahren zum beschichten eines substrats mit einer solchen ueberzugsmasse.
ATE123068T1 (de) Verfahren zur herstellung eines proteins durch hefe mit hilfe eines induzierbaren systems, vektoren und entsprechende transformierte stämme.
DE59005790D1 (de) Verfahren zur Expression eines rekombinanten Gens.
DE60040771D1 (de) Verfahren zur kontrolle der spaltung mit ompt protease
DE69934329D1 (de) Verfahren zur genetischen veränderung einer viralen wildtyp-sequenz
DE59207008D1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins
ATE103341T1 (de) Antikoerper gegen hochkonservierte aminosaeuresequenzen von immunogenen substanzen, verfahren zur herstellung dieser antikoerper, sowie deren verwendung in immunoassays.
KR950000882A (ko) 한국형 씨(c)형 간염 바이러스의 초변화 영역의 뉴클레오티드 서열 및 아미노산 서열
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same